| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |